These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11877595)

  • 1. A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
    Hayakawa M; Okubo M; Katori H; Nagahama K; Murase T; Kobayashi T; Tanaka S; Nakanishi K; Odawara M; Matsushita H; Yamada A
    Am J Kidney Dis; 2002 Mar; 39(3):E15. PubMed ID: 11877595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
    J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of type III hyperlipoproteinemia in Germany.
    Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
    Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
    Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
    Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
    Rall SC; Newhouse YM; Clarke HR; Weisgraber KH; McCarthy BJ; Mahley RW; Bersot TP
    J Clin Invest; 1989 Apr; 83(4):1095-101. PubMed ID: 2539388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report.
    Cautero N; Di Benedetto F; De Ruvo N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; De Blasiis MG; Rompianesi G; Iemmolo RM; Marino M; Bertolotti M; Zivieri S; Gerunda GE
    Transplant Proc; 2010 May; 42(4):1349-51. PubMed ID: 20534298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
    Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
    J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
    Arai T; Yamashita S; Yamane M; Manabe N; Matsuzaki T; Kiriyama K; Kanayama Y; Himeno S; Matsuzawa Y
    Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study.
    Xin Z; Zhihong L; Shijun L; Jinfeng Z; Huiping C; Caihong Z; Daxi J; Leishi L
    Nephrol Dial Transplant; 2009 Mar; 24(3):864-9. PubMed ID: 18840890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
    J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.
    Eto M; Saito M; Okada M; Kume Y; Kawasaki F; Matsuda M; Yoneda M; Matsuki M; Takigami S; Kaku K
    Am J Kidney Dis; 2002 Aug; 40(2):243-51. PubMed ID: 12148096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.